Osteogenesis imperfecta Type I caused by a novel mutation in the start codon of the COL1A1 gene in a Korean family.

Osteogenesis imperfecta (OI) comprises a heterogeneous group of disorders characterized by susceptibility to bone fractures ranging in severity from perinatal death to a subtle increase in fracture frequency. We report the case of a patient who appeared healthy at birth and did not experience any fractures until 12 months of age. We observed blue sclera, frequent fractures without commensurate trauma, nearly normal stature, the absence of dentinogenesis imperfecta, no bony deformity, and no limitation of mobility in the patient--all characteristics suggestive of OI Type I. The patient's mother also had blue sclera and a history of frequent fracture episodes until the age of 15 years. A novel COL1A1 missense mutation (c.2T>G) disrupting the start codon of the gene (ATG to AGG (Met1Arg)) was found in the patient and his mother.

[1]  K. Dwan,et al.  Bisphosphonate therapy for osteogenesis imperfecta. , 2016, The Cochrane database of systematic reviews.

[2]  L. Mazur,et al.  Fractures at Diagnosis in Infants and Children With Osteogenesis Imperfecta , 2013, Journal of pediatric orthopedics.

[3]  Elena Monti,et al.  Current and emerging treatments for the management of osteogenesis imperfecta , 2010, Therapeutics and clinical risk management.

[4]  F. Glorieux,et al.  Osteogenesis imperfecta type III with intracranial hemorrhage and brachydactyly associated with mutations in exon 49 of COL1A2 , 2009, American journal of medical genetics. Part A.

[5]  Balaraman Madhan,et al.  Predicting the clinical lethality of osteogenesis imperfecta from collagen glycine mutations. , 2008, Biochemistry.

[6]  J. Shapiro,et al.  Osteogenesis imperfecta: Epidemiology and pathophysiology , 2007, Current osteoporosis reports.

[7]  N. Kellogg,et al.  Evaluation of Suspected Child Physical Abuse , 2007, Pediatrics.

[8]  F. Glorieux,et al.  Consortium for osteogenesis imperfecta mutations in the helical domain of type I collagen: regions rich in lethal mutations align with collagen binding sites for integrins and proteoglycans , 2007, Human mutation.

[9]  N. Bishop,et al.  Unexplained fractures in infancy: looking for fragile bones , 2007, Archives of Disease in Childhood.

[10]  C. Jenny Evaluating Infants and Young Children With Multiple Fractures , 2006, Pediatrics.

[11]  P. Byers,et al.  Genetic evaluation of suspected osteogenesis imperfecta (OI) , 2006, Genetics in Medicine.

[12]  F. Glorieux,et al.  Osteogenesis imperfecta--clinical and molecular diversity. , 2003, European cells & materials.

[13]  M. Kozak,et al.  Recognition of AUG and alternative initiator codons is augmented by G in position +4 but is not generally affected by the nucleotides in positions +5 and +6 , 1997, The EMBO journal.

[14]  P. Byers,et al.  Osteogenesis imperfecta type I: molecular heterogeneity for COL1A1 null alleles of type I collagen. , 1994, American journal of human genetics.

[15]  D. Peabody,et al.  Translation initiation at non-AUG triplets in mammalian cells. , 1989, The Journal of biological chemistry.

[16]  D. Sillence,et al.  Genetic heterogeneity in osteogenesis imperfecta. , 1979, Journal of medical genetics.

[17]  Joanna Witecka,et al.  Two novelCOL1A1 mutations in patients with osteogenesis imperfecta (OI) affect the stability of the collagen type I triple-helix , 2010, Journal of Applied Genetics.

[18]  G. Pals,et al.  Classification of Osteogenesis Imperfecta revisited. , 2010, European journal of medical genetics.

[19]  P. Byers Killing the messenger: new insights into nonsense-mediated mRNA decay. , 2002, The Journal of clinical investigation.